Gene · 5957
Papers1,540
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,540
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Human retinal organoids with an OPA1 mutation are defective in retinal ganglion cell differentiation and function. | Stem Cell Reports | 2024 | 38101398 | PubTator, text mining | PubMed |
| Glial Fibrillary Acidic Protein Autoimmunity After Aseptic Meningitis: A Report of 2 Cases. | Neurol Neuroimmunol Neuroinflamm | 2024 | 37949666 | PubTator, text mining | PubMed |
| Calpain-specific breakdown fragment in human drusen. | Histol Histopathol | 2024 | 37314158 | PubTator, text mining | PubMed |
| Comparison of Clinical and Immunological Features of Para- and Non-Paraneoplastic Autoimmune Retinopathy in Chinese - A Series of 48 Cases. | Ocul Immunol Inflamm | 2024 | 37043636 | PubTator, text mining | PubMed |
| Pediatric autoimmune retinopathy and optic neuropathy: a case report and a review of the literature. | Front Ophthalmol (Lausanne) | 2023 | 38983022 | PubTator, text mining | PubMed |
| The Potential and Application of iPSCs in Gene and Cell Therapy for Retinopathies and Optic Neuropathies. | Acta Naturae | 2023 | 38234607 | PubTator, text mining | PubMed |
| CXCL13 in Cerebrospinal Fluid: Clinical Value in a Large Cross-Sectional Study. | Int J Mol Sci | 2023 | 38203597 | PubTator, text mining | PubMed |
| Clinical Impact of Pre-Existing Autoantibodies in Patients With SCLC Treated With Immune Checkpoint Inhibitor: A Multicenter Prospective Observational Study. | JTO Clin Res Rep | 2023 | 38162177 | PubTator, text mining | PubMed |
| Retinal Toxicity after Initial Administration of Nivolumab and Ipilimumab. | Case Rep Ophthalmol Med | 2023 | 38155755 | PubTator, text mining | PubMed |
| Association of Circulating Antiretinal Antibodies With Clinical Outcomes in Retinitis Pigmentosa. | Invest Ophthalmol Vis Sci | 2023 | 38088826 | PubTator, text mining | PubMed |
| Unravelling the mechanism of neurotensin recognition by neurotensin receptor 1. | Nat Commun | 2023 | 38071229 | PubTator, text mining | PubMed |
| Pathologic vs. protective roles of hypoxia-inducible factor 1 in RPE and photoreceptors in wet vs. dry age-related macular degeneration. | Proc Natl Acad Sci U S A | 2023 | 38055741 | PubTator, text mining | PubMed |
| Anti-recoverin antibodies in a cerebellar syndrome without retinal involvement. | Acta Biomed | 2023 | 38054667 | PubTator, text mining | PubMed |
| CRX haploinsufficiency compromises photoreceptor precursor translocation and differentiation in human retinal organoids. | Stem Cell Res Ther | 2023 | 38049871 | PubTator, text mining | PubMed |
| ASCL1 induces neurogenesis in human Müller glia. | Stem Cell Reports | 2023 | 38039971 | PubTator, text mining | PubMed |
| Continuous non-adherent culture promotes transdifferentiation of human adipose-derived stem cells into retinal lineage. | Open Life Sci | 2023 | 38027227 | PubTator, text mining | PubMed |
| The neuronal calcium sensor NCS-1 regulates the phosphorylation state and activity of the Gα chaperone and GEF Ric-8A. | Elife | 2023 | 38018500 | PubTator, text mining | PubMed |
| Progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus, not receiving any immunosuppressant medication. | Curr J Neurol | 2023 | 38011386 | PubTator, text mining | PubMed |
| Recent Advances of Adipose-Tissue-Derived Mesenchymal Stem Cell-Based Therapy for Retinal Diseases. | J Clin Med | 2023 | 38002628 | PubTator, text mining | PubMed |
| Insights into genetic diversity and phenotypic variations in domestic geese through comprehensive population and pan-genome analysis. | J Anim Sci Biotechnol | 2023 | 38001525 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5957/papers?page=4